Emergent BioSolutions Analyst Ratings
H.C. Wainwright Initiates Emergent BioSolutions(EBS.US) With Buy Rating, Announces Target Price $15
Emergent BioSolutions Analyst Ratings
Benchmark Co. Maintains Emergent BioSolutions(EBS.US) With Buy Rating, Raises Target Price to $12
Rodman & Renshaw Reiterates Buy on Emergent BioSolutions, Maintains $16 Price Target
Emergent BioSolutions Analyst Ratings
Emergent Biosolutions Price Target Announced at $16.00/Share by Rodman & Renshaw
Rodman & Renshaw Initiates Coverage On Emergent BioSolutions With Buy Rating, Announces Price Target of $16
Emergent BioSolutions Analyst Ratings
Rodman & Renshaw Upgrades Emergent BioSolutions(EBS.US) to Buy Rating, Cuts Target Price to $16
Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target
Emergent BioSolutions Analyst Ratings
Emergent BioSolutions Analyst Ratings
Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target
Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target
Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target
Emergent BioSolutions Analyst Ratings
Emergent BioSolutions Analyst Ratings
Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target
Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target